TranS1 Inc. (TSON: Quote) announced Monday morning that the American Medical Association Current Procedural Terminology Panel has voted to approve an application for a Category I CPT code for L5-S1 spinal fusion, utilizing TranS1's pre-sacral interbody fusion approach with its AxiaLIF implant.
TranS1 has gapped open sharply higher this morning and is now up 1.10 at $4.38 on above average volume. The stock has broken out to a 6-month high.
Click here to receive FREE breaking news email alerts for TranS1, Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com